{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:02:05Z","timestamp":1785441725639,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.transci.2026.104482","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:40:24Z","timestamp":1782517224000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic plasma exchange and immunomodulatory strategies in post-infectious syndromes: A review of immune dysregulation in PTLDS, long COVID, ME\/CFS, and PANS\/PANDAS"],"prefix":"10.1016","volume":"65","author":[{"given":"Gary","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104482_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2026.104482_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1187163","article-title":"ME\/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature","volume":"10","author":"Komaroff","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.transci.2026.104482_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.it.2022.02.008","article-title":"Early clues regarding the pathogenesis of long-COVID","volume":"43","author":"Peluso","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.molmed.2021.06.002","article-title":"Insights from myalgic encephalomyelitis\/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome","volume":"27","author":"Komaroff","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.transci.2026.104482_bib6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41467-024-45107-3","article-title":"Deep phenotyping of post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"15","author":"Walitt","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.transci.2026.104482_bib7","article-title":"Mapping the complexity of ME\/CFS: evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction","volume":"6","author":"Heng","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.transci.2026.104482_bib8","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI138062","article-title":"Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses","volume":"130","author":"Steere","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2026.104482_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41584-021-00648-5","article-title":"Lyme arthritis: linking infection, inflammation and autoimmunity","volume":"17","author":"Lochhead","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.transci.2026.104482_bib10","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2026.104482_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161170","article-title":"Autoimmunity to synovial extracellular matrix proteins in patients with postinfectious Lyme arthritis","volume":"133","author":"Kanjana","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2026.104482_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1711765","article-title":"Toll-like receptor 1 polymorphism is associated with impaired immune tolerance, dysregulated inflammatory responses to Borrelia burgdorferi, and heightened risk of post-infectious Lyme arthritis","volume":"16","author":"Williams","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib13","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/339813","article-title":"Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease","volume":"34","author":"Krause","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2026.104482_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00011-06","article-title":"Coinfections acquired from Ixodes ticks","volume":"19","author":"Swanson","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transci.2026.104482_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pt.2015.09.008","article-title":"Coinfection by Ixodes tick-borne pathogens: ecological, epidemiological, and clinical consequences","volume":"32","author":"Diuk-Wasser","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.transci.2026.104482_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41590-025-02353-x","article-title":"Long COVID involves activation of proinflammatory and immune exhaustion pathways","volume":"27","author":"Aid","year":"2026","journal-title":"Nat Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.transci.2026.104482_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2025.02.005","article-title":"Autoimmunity in long COVID","volume":"155","author":"Talwar","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.transci.2026.104482_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.transci.2026.104482_bib21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/jcm.28.6.1403-1410.1990","article-title":"Immunologic abnormalities in chronic fatigue syndrome","volume":"28","author":"Klimas","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.transci.2026.104482_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M18-1451","article-title":"B-lymphocyte depletion in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial","volume":"170","author":"Fluge","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2026.104482_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307484","article-title":"Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"19","author":"Rekeland","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2026.104482_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0045-2018","article-title":"Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group A streptococci and their sequelae","volume":"7","author":"Cunningham","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.transci.2026.104482_bib25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2026.104482_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383973","article-title":"IVIG response in pediatric acute-onset neuropsychiatric syndrome correlates with reduction in pro-inflammatory monocytes and neuropsychiatric measures","volume":"15","author":"Melamed","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib27","article-title":"Pediatric acute-onset neuropsychiatric syndrome (PANS): clinical report","volume":"155","author":"American Academy of Pediatrics","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2026.104482_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103710","article-title":"Intravenous immunoglobulin as a therapy for autoimmune conditions","volume":"24","author":"Danieli","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transci.2026.104482_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/cap.2016.0148","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome: part II\u2014use of immunomodulatory therapies","volume":"27","author":"Frankovich","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.transci.2026.104482_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2026.104482_bib31","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"7","key":"10.1016\/j.transci.2026.104482_bib32","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/s41380-023-02084-1","article-title":"Clinical improvement of long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis","volume":"28","author":"Achleitner","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.transci.2026.104482_bib33","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41467-025-57198-7","article-title":"Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial","volume":"16","author":"Espa\u00f1a-Cueto","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.transci.2026.104482_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2022.06.014","article-title":"Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis","volume":"122","author":"Qin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.transci.2026.104482_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/vox.13367","article-title":"Efficacy of therapeutic plasma exchange in severe COVID-19 disease: a meta-analysis","volume":"118","author":"Prakash","year":"2023","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2026.104482_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1492672","article-title":"Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19","volume":"15","author":"Guironnet-Paquet","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2026.104482_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13063-024-07982-5","article-title":"IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome including patients with post-acute COVID-19 CFS","volume":"25","author":"Pre\u00dfler","year":"2024","journal-title":"Trials"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022600114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022600114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:31:46Z","timestamp":1785439906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022600114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S147305022600114X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104482","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange and immunomodulatory strategies in post-infectious syndromes: A review of immune dysregulation in PTLDS, long COVID, ME\/CFS, and PANS\/PANDAS","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}